Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
BioInvent International AB Identifier:
First received: November 22, 2011
Last updated: December 10, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)